During the last three months, 17 analysts shared their evaluations of Boston Scientific (NYSE:BSX), revealing diverse outlooks from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

In the assessment of 12-month price targets, analysts unveil insights for Boston Scientific, presenting an average target of $90.47, a high estimate of $100.00, and a low estimate of $78.00. This upward trend is apparent, with the current average reflecting a 6.88% increase from the previous average price target of $84.65.